Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Asylum Ventures is an early-stage venture capital firm founded in 2024, focused on investing $1–2 million in inception-stage startups. The firm positions itself as dedicated to the "creative act of building companies," seeking founders who are more like artists than traditional executives. It recently raised its debut $55 million fund and is based in Brooklyn, New York. The team includes founder Nicholas Chirls (formerly of Notation Capital), Jon Wu, and Mackenzie Regent.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Asylum Ventures.